Autologous stem cell transplantation in Hodgkin's disease

[31] HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATIN (CBV+/-P) AND AUTOLOGOUS TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE WHO FAIL TO ENTER A COMPLETE REMISSION AFTER COMBINATION CHEMOTHERAPY [J]. BLOOD, 1995, 86 (02) : 451 - 456

[32] REECE DE, 1994, BLOOD, V83, P1193

[33] Reuss K, 1996, ANN ONCOL, V7, P109

[34] PHASE I/II STUDY OF CYCLOPHOSPHAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION WITH POSTTRANSPLANT INTERFERON ALFA-2B FOR PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) : 2423 - 2431

[35] Autologous stem-cell transplantation for Hodgkin's disease:: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autolog de Medula Osea Spanish Cooperative Group [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1395 - 1404

[36] High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3101 - 3109

[37] High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT [J]. BONE MARROW TRANSPLANTATION, 1997, 20 (09) : 745 - 752

[38] TRAWEEK ST, 1994, BLOOD, V84, P957

[39] Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: Ten-year results [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1421 - 1430

[40] Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV) [J]. LEUKEMIA & LYMPHOMA, 2001, 40 (5-6) : 499 - 509

[31] HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATIN (CBV+/-P) AND AUTOLOGOUS TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE WHO FAIL TO ENTER A COMPLETE REMISSION AFTER COMBINATION CHEMOTHERAPY [J]. BLOOD, 1995, 86 (02) : 451 - 456

[32] REECE DE, 1994, BLOOD, V83, P1193

[33] Reuss K, 1996, ANN ONCOL, V7, P109

[34] PHASE I/II STUDY OF CYCLOPHOSPHAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION WITH POSTTRANSPLANT INTERFERON ALFA-2B FOR PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) : 2423 - 2431

[35] Autologous stem-cell transplantation for Hodgkin's disease:: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autolog de Medula Osea Spanish Cooperative Group [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1395 - 1404

[36] High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: Results in 175 patients reported to the European Group for Blood and Marrow Transplantation [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3101 - 3109

[37] High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT [J]. BONE MARROW TRANSPLANTATION, 1997, 20 (09) : 745 - 752

[38] TRAWEEK ST, 1994, BLOOD, V84, P957

[39] Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: Ten-year results [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1421 - 1430

[40] Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV) [J]. LEUKEMIA & LYMPHOMA, 2001, 40 (5-6) : 499 - 509